arrow
D

Dalil Hannani

pdc*line pharma sas
H指数:23
被引数:5,319

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metabotypes of Pseudomonas aeruginosa Correlate with Antibiotic Resistance, Virulence and Clinical Outcome in Cystic Fibrosis Chronic Infections
2021-01-2120
OAAI
An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial
2020-04-1250
OAAI
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25 (vol 25, pg 399, 2015)

CTLA-4阻断的抗癌免疫疗法: IL-2受体的强制性贡献和可溶性CD25的负面预后影响 (第25卷,399页,2015页)

2015-03-03149
OAAI
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25
2015-01-13149
OAAI
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

I型干扰素信号传导对化疗疗效的癌细胞自主贡献

2014-10-26876
PREAI